AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

GEHC · NASDAQ · Medical - Devices

GE HealthCare (GEHC)

Makes medical imaging systems, diagnostic agents, patient monitors, and related software and services.

$66.30

After hours+0.02 (+0.03%)

At close$66.28(+2.27%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	4,822	5,206	4,650	4,839	4,863	5,319	4,777	5,006	5,143	4,674	5,131	5,295
Cost of revenue	2,887	3,050	2,749	2,837	2,838	3,044	2,765	3,023	3,153	2,134	3,154	3,115
Gross profit	1,935	2,156	1,902	2,002	2,026	2,275	2,012	1,985	1,990	2,538	1,977	2,180
	1,318	1,467	1,361	1,394	1,349	1,474	1,383	1,329	1,337	1,876	1,462	1,441
Research & development	322	315	324	327	316	344	344	302	292	362	345	323
Selling, general & administrative	996	1,152	1,038	1,067	1,034	1,130	1,040	1,029	1,045	1,036	1,117	1,118
Other expenses	0	0	−1	0	−1	0	−1	−2	0	478	0	0
Operating income	617	689	540	608	676	801	629	654	653	664	515	739
	19	−80	−28	−30	−18	33	63	−41	−10	−462	−10	−46
Interest income	6	7	0	0	5	0	0	6	12	−18	0	0
Interest expense	138	131	138	131	130	111	111	113	123	103	96	114
Other non-operating income	−157	−66	−110	−101	−112	−144	−174	−72	−101	347	−87	−54
Income before tax	636	609	512	578	658	834	692	613	643	202	505	693
Income tax expense	250	193	124	143	168	96	104	113	179	54	94	119
Net income from continuing operations	386	416	388	435	490	738	588	500	464	148	411	574
Discontinued operations	−4	0	0	0	0	0	0	0	0	0	0	0
Net income	375	403	374	428	471	720	564	486	446	184	389	573
EPS, basic	$0.82	$0.89	$0.82	$0.94	$1.03	$1.58	$1.23	$1.06	$0.98	$0.41	$0.85	$1.24
EPS, diluted	$0.82	$0.88	$0.81	$0.93	$1.02	$1.57	$1.23	$1.06	$0.98	$0.38	$0.85	$1.24
Weighted average shares, basic	455	455	456	457	457	457	457	457	456	457	456	453
Weighted average shares, diluted	458	458	459	459	459	459	459	458	457	460	457	454
EBITDA	927	899	798	858	931	1,085	939	874	902	865	755	953
Depreciation & amortization	153	144	148	149	143	140	136	148	148	548	153	160
EBIT	774	755	650	709	788	945	803	726	754	317	602	793